WA Health healthcare public affairs and communications experts

WA Health combines specialist insight with imaginative solutions to tackle the major issues in healthcare today. We excel at targeted campaigns that make sure our clients influence the agenda, nationally and locally.

Our team is creative, flexible and experienced at delivering tailored programmes informed by our deep knowledge of the health, NHS, care, medical devices and pharmaceutical sectors.

With backgrounds in politics, government, charities, PR and the NHS, our consultants have the breadth of expertise to create innovative public affairs and communications strategies in a complex, ever-changing healthcare environment.

WA Health provides a comprehensive suite of healthcare public affairs and communications services:

Engagement

  • Healthcare campaigns
  • Public affairs and government relations
  • Market access programmes
  • Stakeholder relations

Research and Insight

  • Health policy analysis and insight
  • Understanding public and patient opinion
  • Data analysis and digital insight
  • Positioning and message development

Communications

  • Media relations and PR support
  • Crisis communications and media training
  • Press office and social media management
  • Internal communications

Advisory

  • Strategic counsel
  • Reputation management
  • Thought leadership
  • Coalition secretariats

NICE’s HTA methodology to undergo long anticipated review

At a recent meeting of the All-Party Parliamentary Group (APPG) on Access to Medicines and Medical Devices, NICE’s Chief Executive, Sir Andrew Dillon discussed the long anticipated NICE methods review. Here are five key takeaways: Explicit recognition of NICE’s role in the wider system NICE has always stated that it is accountable to the DepartmentRead more

Are investors ready for primary care networks?

The NHS Long Term Plan, published in January 2019, identifies newly established primary care networks (PCNs) as important drivers of NHS reform. By June 2019, PCNs will bring local GP practices together into geographical networks, covering populations of between 30,000-50,0000 patients. GP practices have worked collaboratively for years, but the new GP contract, taking effectRead more

US scrutiny, UK ramifications: pharma pricing in the political spotlight

Pharma companies and their approach to pricing are back in the political spotlight. While there are major differences between US parties on most issues, the debate on drug pricing has united them as last week top executives from seven major pharmaceutical companies were called to testify in front of Congress. A combative session lasted severalRead more

See previous Healthcare articles